scholarly article | Q13442814 |
P50 | author | Alexandre F. Stewart | Q47502513 |
Jonathan A. Kirk | Q51424754 | ||
P2093 | author name string | R John Solaro | |
Chad M Warren | |||
Guy A MacGowan | |||
Murali Chandra | |||
Sanjeev G Shroff | |||
Caroline Evans | |||
Stephen H Smith | |||
Ranganath Mamidi | |||
P2860 | cites work | Heart failure-associated alterations in troponin I phosphorylation impair ventricular relaxation-afterload and force-frequency responses and systolic function | Q80174851 |
Interaction between myosin heavy chain and troponin isoforms modulate cardiac myofiber contractile dynamics | Q80600695 | ||
Phosphorylation of cardiac troponin I by mammalian sterile 20-like kinase 1 | Q24312146 | ||
Phosphorylation or glutamic acid substitution at protein kinase C sites on cardiac troponin I differentially depress myofilament tension and shortening velocity | Q28205242 | ||
Inhibition of PKC phosphorylation of cTnI improves cardiac performance in vivo | Q28238928 | ||
Cardiac troponin I mutants. Phosphorylation by protein kinases C and A and regulation of Ca(2+)-stimulated MgATPase of reconstituted actomyosin S-1 | Q28291787 | ||
Partial replacement of cardiac troponin I with a non-phosphorylatable mutant at serines 43/45 attenuates the contractile dysfunction associated with PKCepsilon phosphorylation | Q28294519 | ||
Ischemic dysfunction in transgenic mice expressing troponin I lacking protein kinase C phosphorylation sites | Q28505911 | ||
Effect of Ca2+ on cross-bridge turnover kinetics in skinned single rabbit psoas fibers: implications for regulation of muscle contraction | Q33572224 | ||
Kinases as therapeutic targets for heart failure | Q35058555 | ||
Single amino acid sequence polymorphisms in rat cardiac troponin revealed by top-down tandem mass spectrometry | Q35852956 | ||
In vivo phosphorylation of cardiac troponin I by protein kinase Cbeta2 decreases cardiomyocyte calcium responsiveness and contractility in transgenic mouse hearts | Q37387021 | ||
Tyrosine phosphorylation modifies protein kinase C delta-dependent phosphorylation of cardiac troponin I. | Q41851995 | ||
Unraveling molecular complexity of phosphorylated human cardiac troponin I by top down electron capture dissociation/electron transfer dissociation mass spectrometry | Q42435438 | ||
In vivo and in vitro analysis of cardiac troponin I phosphorylation | Q42469737 | ||
Functional effects of protein kinase C-mediated myofilament phosphorylation in human myocardium. | Q42488512 | ||
Troponin I serines 43/45 and regulation of cardiac myofilament function | Q42524860 | ||
Phosphorylation of troponin I controls cardiac twitch dynamics: evidence from phosphorylation site mutants expressed on a troponin I-null background in mice | Q43948817 | ||
p21-activated kinase increases the calcium sensitivity of rat triton-skinned cardiac muscle fiber bundles via a mechanism potentially involving novel phosphorylation of troponin I. | Q44145598 | ||
Cross-bridge kinetics modeled from myoplasmic [Ca2+] and LV pressure at 17 degrees C and after 37 degrees C and 17 degrees C ischemia | Q44280854 | ||
Protein kinase C and A sites on troponin I regulate myofilament Ca2+ sensitivity and ATPase activity in the mouse myocardium | Q44552168 | ||
Cardiac troponin I threonine 144: role in myofilament length dependent activation | Q46920743 | ||
Roles of phosphorylation of myosin binding protein-C and troponin I in mouse cardiac muscle twitch dynamics. | Q47350570 | ||
Pressure-calcium relationships in perfused mouse hearts. | Q51955821 | ||
Ejection has both positive and negative effects on left ventricular isovolumic relaxation. | Q52250919 | ||
Troponin I protein kinase C phosphorylation sites and ventricular function | Q57775275 | ||
Interrelating of ventricular pressure and intracellular calcium in intact hearts | Q73757722 | ||
PKC-betaII sensitizes cardiac myofilaments to Ca2+ by phosphorylating troponin I on threonine-144 | Q79162724 | ||
Myofilament calcium sensitivity does not affect cross-bridge activation-relaxation kinetics | Q79326358 | ||
P433 | issue | 12 | |
P304 | page(s) | 1232-1239 | |
P577 | publication date | 2009-10-22 | |
P1433 | published in | Circulation Research | Q2599020 |
P1476 | title | Left ventricular and myocardial function in mice expressing constitutively pseudophosphorylated cardiac troponin I | |
P478 | volume | 105 |
Q36418270 | A Priori Identifiability Analysis of Cardiovascular Models |
Q36003703 | AMP-activated protein kinase phosphorylates cardiac troponin I at Ser-150 to increase myofilament calcium sensitivity and blunt PKA-dependent function. |
Q35529137 | Ablation of p21-activated kinase-1 in mice promotes isoproterenol-induced cardiac hypertrophy in association with activation of Erk1/2 and inhibition of protein phosphatase 2A |
Q35668835 | Augmented phosphorylation of cardiac troponin I in hypertensive heart failure |
Q91105917 | Bisphenol S rapidly depresses heart function through estrogen receptor-β and decreases phospholamban phosphorylation in a sex-dependent manner |
Q33787533 | Calcium sensitivity, force frequency relationship and cardiac troponin I: critical role of PKA and PKC phosphorylation sites |
Q58656240 | Cardiac Actin Capping Protein Reduction and Protein Kinase C Inhibition Maintain Myofilament Function During Cardioplegic Arrest |
Q92319811 | Cardiac contractile dysfunction and protein kinase C-mediated myofilament phosphorylation in disease and aging |
Q37410579 | Cardiac resynchronization sensitizes the sarcomere to calcium by reactivating GSK-3β. |
Q34980505 | Cardiac troponin I Pro82Ser variant induces diastolic dysfunction, blunts β-adrenergic response, and impairs myofilament cooperativity |
Q35634087 | Ceramide-mediated depression in cardiomyocyte contractility through PKC activation and modulation of myofilament protein phosphorylation |
Q36910012 | Conserved Asp-137 is important for both structure and regulatory functions of cardiac α-tropomyosin (α-TM) in a novel transgenic mouse model expressing α-TM-D137L |
Q36923928 | Contractile protein phosphorylation predicts human heart disease phenotypes |
Q38816583 | Contribution of Post-translational Phosphorylation to Sarcomere-Linked Cardiomyopathy Phenotypes. |
Q36309706 | Contributions of Ca2+-Independent Thin Filament Activation to Cardiac Muscle Function |
Q58599424 | Diabetes with heart failure increases methylglyoxal modifications in the sarcomere, which inhibit function |
Q37209216 | Divergent effects of α- and β-myosin heavy chain isoforms on the N terminus of rat cardiac troponin T. |
Q38853345 | Early sensitization of myofilaments to Ca2+ prevents genetically linked dilated cardiomyopathy in mice |
Q50598076 | Functional communication between PKC-targeted cardiac troponin I phosphorylation sites. |
Q36984316 | Functionally conservative substitutions at cardiac troponin I S43/45. |
Q26825137 | Human cardiac troponin complex. Structure and functions |
Q34995673 | Independent modulation of contractile performance by cardiac troponin I Ser43 and Ser45 in the dynamic sarcomere. |
Q37299705 | Instability in the central region of tropomyosin modulates the function of its overlapping ends |
Q26852120 | Integration of troponin I phosphorylation with cardiac regulatory networks |
Q38050130 | Interpreting genetic effects through models of cardiac electromechanics |
Q30049005 | Multiple Reaction Monitoring to Identify Site-Specific Troponin I Phosphorylated Residues in the Failing Human Heart |
Q34438891 | Novel function of cardiac protein kinase D1 as a dynamic regulator of Ca2+ sensitivity of contraction |
Q35014341 | PKCα-specific phosphorylation of the troponin complex in human myocardium: a functional and proteomics analysis |
Q35659681 | Phosphorylation of cardiac Myosin-binding protein-C is a critical mediator of diastolic function |
Q36599563 | Protein kinase C depresses cardiac myocyte power output and attenuates myofilament responses induced by protein kinase A |
Q41886131 | Protein kinase C phosphomimetics alter thin filament Ca2+ binding properties |
Q36339391 | Rat cardiac troponin T mutation (F72L)-mediated impact on thin filament cooperativity is divergently modulated by α- and β-myosin heavy chain isoforms |
Q27329916 | Rationally engineered Troponin C modulates in vivo cardiac function and performance in health and disease |
Q34696170 | Redox signaling and cardiac sarcomeres |
Q37751888 | Sarcomere control mechanisms and the dynamics of the cardiac cycle |
Q33912875 | Sub-proteomic fractionation, iTRAQ, and OFFGEL-LC-MS/MS approaches to cardiac proteomics |
Q38224427 | Targeted proteomics of myofilament phosphorylation and other protein posttranslational modifications |
Q47687870 | The continuing evolution of cardiac troponin I biomarker analysis: from protein to proteoform |
Q84959273 | The effects of slow skeletal troponin I expression in the murine myocardium are influenced by development-related shifts in myosin heavy chain isoform |
Q37142798 | The β-arrestin-biased ligand TRV120023 inhibits angiotensin II-induced cardiac hypertrophy while preserving enhanced myofilament response to calcium |
Q28274412 | Why does troponin I have so many phosphorylation sites? Fact and fancy |
Q42022510 | Why is it important to analyze the cardiac sarcomere subproteome? |
Q37514915 | β-Arrestin mediates the Frank-Starling mechanism of cardiac contractility |
Search more.